Cite
MLA Citation
Cathy Eng et al.. “418 A phase 1, dose escalation and dose expansion study of SQZ PBMC HPV as monotherapy and in combination with atezolizumab in HLA-A*02+ Patients with HPV16+ recurrent, or metastatic solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A254–A255. http://access.bl.uk/ark:/81055/vdc_100144724844.0x000006